Decision reverses decades of precedent and calls into question the validity of literally thousands of issued Australian patents Like the U.S. Supreme Court, the High Court of Australia has determined that Myriad’s patents directed to purified and isolated DNA molecules encoding the BRCA genes are unpatentable. Indeed, the High Court of Australia went one step … Continue Reading